Switch to:

Key Ratios

New Key Statistics Module, Z-Score and F-Score
Market Cap $M626Revenue (TTM) $M5.5Net Margin (%)-2,068.8Altman Z-Score5.4
Enterprise Value $M487EPS (TTM) $-3.1Operating Margin %-2,049.3Piotroski F-Score4
P/E(ttm)--Beneish M-Score-0.8Pre-tax Margin (%)-2,068.8Higher ROA y-yN
Price/Book4.510-y EBITDA Growth Rate %-14.1Quick Ratio5.2Cash flow > EarningsY
Price/Sales1115-y EBITDA Growth Rate %-10.5Current Ratio5.2Lower Leverage y-yY
Price/Free Cash Flow--y-y EBITDA Growth Rate %--ROA % (ttm)-61.3Higher Current Ratio y-yY
Dividend Yield %--PEG--ROE % (ttm)-72.8Less Shares Outstanding y-yN
Payout Ratio %--Shares Outstanding M38.5ROIC % (ttm)--Gross Margin Increase y-yN

Gurus Latest Trades with DVAX

Number of guru portfolios checked: 68.
TickerGuruDate Action
Impactdown Price Range
(Average)*
Current Price Change from Average Comment Current Shares
DVAXJohn Paulson 2016-06-30 Reduce$13.2 - $22.74
($17.12)
$ 16.27-5%Reduce -12.87%174,000
DVAXJohn Paulson 2016-03-31 Add0.01%$16.12 - $29.7
($20.26)
$ 16.27-20%Add 49.25%199,700
DVAXJohn Paulson 2015-12-31 Buy 0.02%$22.08 - $27.9
($25.09)
$ 16.27-35%New holding133,800
DVAXGeorge Soros 2012-06-30 Sold Out -0.03%$35.2 - $52.6
($42.76)
$ 16.27-62%Sold Out0
DVAXGeorge Soros 2012-03-31 Reduce-0.09%$32.8 - $50.3
($40.41)
$ 16.27-60%Reduce -62.50%37,500
DVAXGeorge Soros 2011-12-31 Buy 0.14%$18.2 - $33.3
($28.15)
$ 16.27-42%New holding100,000
DVAXGeorge Soros 2011-09-30 Sold Out -0.0026%$18.4 - $31.6
($24.39)
$ 16.27-33%Sold Out0
DVAXGeorge Soros 2011-06-30 Buy 0.0026%$24.6 - $28.1
($26.35)
$ 16.27-38%New holding6,610
Premium Real Time Picks are included for Premium Members only!!
*The price and date might not be the actual time and price at which the transactions were made. In the case of institutional owners, the date is stated as the last day of their fiscal quarter. The prices are estimates if no accurate information available. Foreign holdings may not be included.

DVAX is held by these investors:

Premium Most recent portfolio changes are included for Premium Members only!


DVAX: Insider Buys/Sells

Click Here for All Insider Trades.
InsiderPosition Date Trades Shares Trade Price ($) Change (%) Details
Janssen RobertVice President 2016-06-28Buy1,452$13.6818.93view
Gray EddieCEO and Director 2016-05-20Buy2,750$15.574.5view
Janssen RobertVice President 2016-05-12Buy1,000$15.127.61view
Janssen RobertVice President 2015-10-08Buy100$23.34-30.29view
Gray EddieCEO and Director 2014-08-14Buy2,500$14.99.19view
KISNER DANIEL LDirector 2013-10-30Buy1,000$10.850.65view
ORONSKY ARNOLD LDirector 2013-10-30Buy18,605$10.850.65view
Phillips Peggy VDirector 2013-10-30Buy9,302$10.850.65view
Janssen RobertChief Medical Officer and VP 2013-07-09Sell0$050.65view
Novack David FSenior Vice President 2013-03-25Sell0$050.65view

Press Releases about DVAX :

Quarterly/Annual Reports about DVAX:

News about DVAX:

Articles On GuruFocus.com
William Blair’s Top BioPharmaceutical Stock Picks for Q1 2015 Dec 23 2014 
Two Promising Health Care Stocks with Market Capitalizations Under $500 Million Jun 11 2014 
Top Three Largest Insider Buys of the Past Week Nov 05 2013 
Steven Cohen, George Soros, John Paulson All Add to Holdings Mar 07 2012 
Dynavax Technologies Corp. Reports Operating Results (10-Q) Aug 02 2010 
Dynavax Technologies Corp. Reports Operating Results (10-Q) May 10 2010 
Price % Loser Stocks of The Day: SIGA Technologies Inc., Universal Travel Group, U.S. Concrete Inc., Dec 10 2009 
Dynavax Technologies Corp. Reports Operating Results (10-Q) Oct 30 2009 
Dynavax Technologies Corp. Reports Operating Results (10-Q) Aug 06 2009 
Dynavax Technologies Corp. Reports Operating Results (10-Q) Apr 30 2009 

More From Other Websites
ETF’s with exposure to Dynavax Technologies Corp. : August 25, 2016 Aug 25 2016
DYNAVAX TECHNOLOGIES CORP Financials Aug 20 2016
ETF’s with exposure to Dynavax Technologies Corp. : August 12, 2016 Aug 12 2016
Dynavax Technologies Corp. :DVAX-US: Earnings Analysis: Q2, 2016 By the Numbers : August 10, 2016 Aug 10 2016
DYNAVAX TECHNOLOGIES CORP Files SEC form 8-K, Results of Operations and Financial Condition, Other... Aug 08 2016
Looking At Dynavax Technologies Corporation (DVAX)’s Upcoming Hep B Catalysts Aug 08 2016
DYNAVAX TECHNOLOGIES CORP Files SEC form 10-Q, Quarterly Report Aug 08 2016
Dynavax Reports Second Quarter 2016 Financial Results Aug 05 2016
Dynavax Announces FDA Advisory Committee Meeting to Review HEPLISAV-B Aug 05 2016
Dynavax Technologies reports 2Q loss Aug 05 2016
Dynavax Technologies reports 2Q loss Aug 05 2016
Dynavax Reports Second Quarter 2016 Financial Results Aug 05 2016
Dynavax Announces FDA Advisory Committee Meeting to Review HEPLISAV-B Aug 05 2016
5 Breakout Stocks to Buy for Big Gains Aug 05 2016
The Zacks Analyst Blog Highlights: Aratana Therapeutics, Dynavax Technologies, Heron Therapeutics... Aug 05 2016
Drug Stocks' Earnings to Watch on Aug 5: PETX, DVAX & More Aug 04 2016
Dynavax Technologies Corp. breached its 50 day moving average in a Bullish Manner : DVAX-US : July... Jul 22 2016
Dynavax Technologies Corp. – Value Analysis (NASDAQ:DVAX) : July 18, 2016 Jul 18 2016
Coverage Initiated on Select Biotech Stocks Jul 13 2016
Dynavax Technologies Corp. breached its 50 day moving average in a Bullish Manner : DVAX-US : July... Jul 11 2016

Add Notes, Comments

If you want to ask a question or report a bug, please create a support ticket.
Get WordPress Plugins for easy affiliate links on Stock Tickers and Guru Names | Earn affiliate commissions by embedding GuruFocus Charts
GuruFocus Affiliate Program: Earn up to $400 per referral. ( Learn More)